Microphthalmia, Lenz type

Microphthalmia, Lenz type (also known as Lenz microphthalmia syndrome or Lenz dysplasia) is a rare X-linked genetic disorder characterized primarily by microphthalmia (abnormally small eyes) or anophthalmia (absence of one or both eyes), leading to significant visual impairment or blindness. The condition was first described by Widukind Lenz in 1955 and predominantly affects males, while carrier females may show mild or no features. Beyond the ocular abnormalities, Lenz microphthalmia syndrome affects multiple body systems. Key associated features include intellectual disability of variable severity, skeletal anomalies (such as abnormalities of the fingers and toes including syndactyly, clinodactyly, or camptodactyly), dental anomalies, and malformations of the ears. Genitourinary abnormalities, including cryptorchidism and renal anomalies, are frequently reported. Some patients may also present with cardiac defects and microcephaly. The clinical presentation can be highly variable, even within the same family. Two genetic loci have been associated with this condition: MCOPS1 (Xq27-q28) and MCOPS2, which is caused by mutations in the BCOR gene on Xp11.4. There is currently no cure for Lenz microphthalmia syndrome. Treatment is supportive and multidisciplinary, focusing on management of individual symptoms. This may include surgical interventions for ocular or skeletal anomalies, use of ocular prostheses, special education services for intellectual disability, and monitoring and treatment of genitourinary or cardiac complications. Early intervention programs and genetic counseling for affected families are recommended.

Common questions about Microphthalmia, Lenz type